Assessing for comorbidities, determinants and disability during TB treatment
IJTLD Open
.
2024 Feb 1;1(2):99-100.
doi: 10.5588/ijtldopen.23.0441.
eCollection 2024 Feb.
Authors
K Viney
1
,
A Baddeley
1
,
E Jaramillo
1
,
M Calvi
1
,
A Carlqvist
1
,
F Mavhunga
1
Affiliation
1
Global Tuberculosis Programme, World Health Organization, Geneve, Switzerland.
PMID:
38966693
PMCID:
PMC11221591
DOI:
10.5588/ijtldopen.23.0441
No abstract available
Grants and funding
001/WHO_/World Health Organization/International